Coronapod: Why COVID antibody treatments may not be the answer
Listen now
Description
In the early days of the pandemic, researchers raced to identify the most potent antibodies produced by the immune system in response to SAR-COV-2 infection and produce them in bulk. The resulting ‘monoclonal antibodies’ have since been tested in a variety of settings as treatments for COVID-19. But despite promising clinical trial results and several therapies having already been approved, antibody therapies have not yet played a large role in the fight against COVID-19. In this episode of Coronapod, we ask why. News: COVID antibody treatments show promise for preventing severe disease News: Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit? Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.   See acast.com/privacy for privacy and opt-out information.
More Episodes
People that have recovered from COVID are seeing stronger immune responses after vaccination than those that never contracted the virus. Researchers are now racing to unpick what is behind this powerful 'hybrid immunity'. In this episode of Coronapod, we discuss a series of studies which are...
Published 10/25/21
An ancient solar storm helps pinpoint when Vikings lived in the Americas, and using magnets to deftly move non-magnetic metals.   See acast.com/privacy for privacy and opt-out information.
Published 10/20/21
Hundreds of scientists have responded to a survey asking about harassment and abuse during the pandemic. The results paint a picture which is as concerning as it is shocking. In this episode of Coronapod we discuss the kinds of abuse scientists are facing, try to pick apart where it is comes from...
Published 10/18/21